This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Practice Guideline

. 2006 May 16;47(10):2130-9.

doi: 10.1016/j.jacc.2006.04.026.

AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute

AHA; ACC; National Heart, Lung, and Blood Institute; Sidney C Smith Jr, Jerilyn Allen, Steven N Blair, Robert O Bonow, Lawrence M Brass, Gregg C Fonarow, Scott M Grundy, Loren Hiratzka, Daniel Jones, Harlan M Krumholz, Lori Mosca, Thomas Pearson, Marc A Pfeffer, Kathryn A Taubert

PMID: 16697342
DOI: 10.1016/j.jacc.2006.04.026

Free article

Practice Guideline

AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute

AHA et al. J Am Coll Cardiol. 2006.

Free article

. 2006 May 16;47(10):2130-9.

doi: 10.1016/j.jacc.2006.04.026.

Authors

AHA; ACC; National Heart, Lung, and Blood Institute; Sidney C Smith Jr, Jerilyn Allen, Steven N Blair, Robert O Bonow, Lawrence M Brass, Gregg C Fonarow, Scott M Grundy, Loren Hiratzka, Daniel Jones, Harlan M Krumholz, Lori Mosca, Thomas Pearson, Marc A Pfeffer, Kathryn A Taubert

PMID: 16697342
DOI: 10.1016/j.jacc.2006.04.026

No abstract available

PubMed Disclaimer

Similar articles

AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA; AHA/ACC; National Heart, Lung, and Blood Institute. Smith SC Jr, et al. Circulation. 2006 May 16;113(19):2363-72. doi: 10.1161/CIRCULATIONAHA.106.174516. Circulation. 2006. PMID: 16702489 No abstract available.
Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
Anselmino M, Malmberg K, Ohrvik J, Rydén L; Euro Heart Survey Investigators. Anselmino M, et al. Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):216-23. doi: 10.1097/HJR.0b013e3282f335d0. Eur J Cardiovasc Prev Rehabil. 2008. PMID: 18391651
[Primary and secondary prevention of coronary artery disease].
Mohri M. Mohri M. Fukuoka Igaku Zasshi. 2003 Mar;94(3):43-7. Fukuoka Igaku Zasshi. 2003. PMID: 12784708 Review. Japanese. No abstract available.
Prevalence of use of cardiovascular drugs in 499 patients with suspected coronary artery disease at time of hospitalization for coronary angiography and in 357 patients with obstructive coronary artery disease documented by coronary angiography.
Mazar M, Schair B, Aronow WS, Khalique O, Lehrman SG. Mazar M, et al. Am J Ther. 2008 Sep-Oct;15(5):458-60. doi: 10.1097/MJT.0b013e318032599a. Am J Ther. 2008. PMID: 18806522
[Treatment of coronary artery disease in a patient with adult-onset diabetes mellitus].
Syvänne M. Syvänne M. Duodecim. 1999;115(10):1167-73. Duodecim. 1999. PMID: 11877856 Review. Finnish. No abstract available.

See all similar articles

Cited by

Coronary artery disease is under-diagnosed and under-treated in advanced lung disease.
Reed RM, Eberlein M, Girgis RE, Hashmi S, Iacono A, Jones S, Netzer G, Scharf S. Reed RM, et al. Am J Med. 2012 Dec;125(12):1228.e13-1228.e22. doi: 10.1016/j.amjmed.2012.05.018. Epub 2012 Sep 6. Am J Med. 2012. PMID: 22959785 Free PMC article.
Effectiveness and tolerability of ezetimibe co-administered with statins versus statin dose-doubling in high-risk patients with persistent hyperlipidemia: The EZE(STAT)2 trial.
Shekhar Pandey A, Bissonnette S, Boukas S, Rampakakis E, Sampalis JS. Shekhar Pandey A, et al. Arch Med Sci. 2011 Oct;7(5):767-75. doi: 10.5114/aoms.2011.25550. Epub 2011 Nov 8. Arch Med Sci. 2011. PMID: 22291820 Free PMC article.
Intensive cholesterol-lowering therapy improves large artery elasticity in acute myocardial infarction patients.
Jia X, Wei M, Fu X, Gu X, Fan W, Zhang J, Xue L. Jia X, et al. Heart Vessels. 2009 Sep;24(5):340-6. doi: 10.1007/s00380-008-1132-z. Epub 2009 Sep 27. Heart Vessels. 2009. PMID: 19784816 Clinical Trial.
Social Support and Self-Efficacy as Mediating Factors Affecting the Association Between Depression and Medication Adherence in Older Patients with Coronary Heart Disease: A Multiple Mediator Model with a Cross-Sectional Study.
Zhou Y, Huo Q, Du S, Shi X, Shi Q, Cui S, Feng C, Du X, Wang Y. Zhou Y, et al. Patient Prefer Adherence. 2022 Feb 4;16:285-295. doi: 10.2147/PPA.S337634. eCollection 2022. Patient Prefer Adherence. 2022. PMID: 35153475 Free PMC article.
Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events.
Jaeger BR, Richter Y, Nagel D, Heigl F, Vogt A, Roeseler E, Parhofer K, Ramlow W, Koch M, Utermann G, Labarrere CA, Seidel D; Group of Clinical Investigators. Jaeger BR, et al. Nat Clin Pract Cardiovasc Med. 2009 Mar;6(3):229-39. doi: 10.1038/ncpcardio1456. Nat Clin Pract Cardiovasc Med. 2009. PMID: 19234501 Clinical Trial.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information